Usefulness of six indirect methods to evaluate drug therapy compliance in non insulin dependent diabetes mellitus;Validez de seis metodos indirectos para valorar el cumplimiento del tratamiento farmacologico en la diabetes no insulinodependiente

Revista Clinica Espanola

Volumn 197, Issue 8, 1997, Pages 555-559

  Pineiro Chousa F ^a   Gil Guillen V F ^a   Donis Otero, M ^a   Orozco Beltran D ^a   Pastor Lopez R ^a   Merino Sanchez J ^a  

^a UNIVERSITY OF ALICANTE   (Spain)

Author keywords

compliance; hypoglycemic agents; methods; non insulin dependent diabetes

Indexed keywords

ORAL ANTIDIABETIC AGENT; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ARTICLE; DRUG USE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; AGED; BLOOD; COMPARATIVE STUDY; EVALUATION; FEMALE; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PRIMARY HEALTH CARE; RANDOMIZATION;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; EVALUATION STUDIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PRIMARY HEALTH CARE; RANDOM ALLOCATION;

EID: 0030876610     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Watkins JD, Williams R, Martín DA, Hogan MD, Anderson E. A study of diabetic patients at home. Am J Pub Health 1967; 57:452-459.
2. Sclar D, Skaer T. Effect of medication utilization review on medicaid health care expenditures: a case study of patients with non-insulin-dependent diabetes mellitus. J Res Pharma Ec 1991; 3:75-89.
3. Merino J, Gil V, Belda J. Métodos de conocimiento y medida de la observancia. En: Martínez Amenos A, ed. La observancia en el tratarnianto de la hipertensión arterial Barcelona: Ediciones Doyma, 1993; 7-30.
4. Sackett DL. Methods for compliance research. En: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in health care. Baltimore: Johns Hopkns University, 1979; 323-337.
5. Gil V, Merino J. Cumplimiento terapéutico. En: Gil VF, Merino J, Orozco D, et al. Tratado de epidemiología clinica. Madrid: Ed. DuPont Pharma SA, 1995; 299-314.
6. Evans L, Spelman M. The problem of non-compliance with drug therapy. Drugs 1983; 25:63-76.
7. McDonald M, Grimm RH. Compliance with hypertension treatment Strategies for improving patient cooperation. Postgrad Med 1985; 77:233-242.
8. Val A, Amorós G, Martínez P, Femández ML, Leán M. Estudio descriptivo del cumplirniento del tratamiento farinacológico antihipertensivo y validación del test de Morisky y Green. Aten Primaria 1992; 10:767-770.
9. Gil V, Belda J, Mun̄oz C, Martínez JL, Soriano JE, Merino J. Validez de cuatro métodos indirectos que valoran el cumplimiento terapéutico en la hipertensión arterial. Rev Clin Esp 1993; 193:363-367.
10. Gil V. Pineda M, Martinez JL, Belda J, Santos ML, Merino J. Validez de seis métodos indirectos para valorar el cumplimiento terapéutico en la hipertensión arterial. Med Clin (Barc) 1994; 102:532-536.
11. Marquez E, Gutiérrez C, Jiménez C, Franco C, Baquero C, Ruiz R. Observancia terapéutica en la hipertensión arterial. Validación de métodos indirectos que valoran el cumplirniento terapéutico. Aten Primaria 1995; 16:496-500.
12. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other cathegories of glucose tolerance. Diabetes 1979; 28:1.039-1.057.
13. Haynes RB, Sackett DL, Tugwell P, eds. Cumplimiento. En: Epidemiología clínica, una ciencia básica para la medicina clínica. Madrid: Díaz de Santos SA, 1989; 250-290.
14. Sackett DL, Haynes RB, Gibson ES. Hypertension control, compliance and science. Am Heart J 1977; 94:666-667.
15. Sackett DL, Haynes RB, Gibson ES. Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet 1975; 1:1.205-1.207.
16. Diehl AK, Sugarek NJ, Bauer RL. Medication compliance in non-insulin-dependent diabetes: a randomized comparison of chlorpropamide and insulin. Diabetes Care 1985; 8:219-223.
17. Matsuyama JR, Mason BJ, Jue SG. Pharmacist's interventions using an electronic medication event monitoring device's adherence data uersus pill counts. Ann Pharmacother 1993; 27:851-855.
18. Alberti KG, Gries FA, Jervell J, Krans HM. A desktop guide for the mangament of non-insulin-dependent diabetes mellitus (NIDDM): an update. Diabetic Med 1994; 11:899-909.
19. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24:67-74.
20. Batalla C, Blanquer A, Ciurana R, García M, Cases E, Pérez A, et al. Cumplimiento de la prescripción farmacoológica en pacientes hipertensos. Aten Primaria 1984; 1:185-191.
21. Haynes RB. A critical review of the determinants of patient compliance with therapeutic regimens. En: Sackett DL, Haynes RB, eds. Compliance in health care. Baltimore: The Johns Hopkins University Press, 1976; 27-39.
22. Mason BJ, Matsuyama JR, Jue SG. Assessment of sulfonylurea adherence and metabolic control. Diab Educ 1995; 21:52-57.
23. Dhiel AK, Bauer RL, Sugarek N. Correlates of medication compliance in non insulindependent diabetes mellitus. South Med J 1987; 80:332-335
24. Wing RR, Epstein LH, Nowalk MP, Scott N, Koeske R. Compliance to self-monitoring of blood glucose: a marked-item technique compared with self-report. Diabetes Care 1985; 8:456-460.
25. a ed). Ciencia bésica para la medicina clinica. Madrid: Médica Panamericana SA, 1994; 249-278.
26. Johnson SB. Methodological issues in diabetes research. Measuring adherence. Diabetes Care 1992; 15:1.658-1.667.
27. Haynes RB, Sackett DL, Taytor DW, Snow JC. Annotated and indexed bibliography on compliance therapeutic and preventive regimens. En: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in health care. Baltimore: Johns Hopkins University, 1979; 24-40.